Positive Feedback Regulation between USP15 and ERK2 Promotes Cartilage Repair Through the TGF-β/SMAD2 signaling

Wenjuan Wang,Yanhui Zhu,Zhenyu Sun,Chen Jin,Xiang Wang
DOI: https://doi.org/10.21203/rs.3.rs-93713/v1
2020-10-22
Abstract:Abstract The transforming growth factor-β (TGF-β) signaling pathway plays an essential role in maintaining homeostasis in joints affected by osteoarthritis (OA). Here, we detected that overexpression of USP15, rather than USP15 C269S (a USP15 mutant), activated p-SMAD2 in ATDC5 cells, which also went down by USP15 knocked out followed by the latest gene editing technology Crispr/Cas9. And we established rat knee OA models through anterior cruciate ligament transection and partial medial meniscectomy (ACLT+pMMx) after 8 weeks and conducted the corresponding Adeno-associated virus (AAV) intraarticular injections. Next, experimental data including immunohistochemical staining, HE/Safranin-O fast green staining, histological evidence analysis, relevant Osteoarthritis Research Society International (OARSI) scores, expression of molecules involved in cartilage anabolism and so on indicated that USP15 can reduce damaged cartilage by activating TGF-β signaling pathway in vivo. We further observed that ERK2 of non-SMAD signaling can maintain the cartilage phenotype by regulating the TGF-β signaling pathway through USP15 in vitro and in vivo. Most importantly, USP15 is required during this process and can form a complex with ERK2 to regulate ubiquitination of ERK2. Specifically, USP15, instead of USP15 C269S, deubiquitinates and activates ERK2, followed by translocation of phosphorylated ERK2 from the cytoplasm to the nucleus. Taken together, our study revealed a positive feedback regulation between USP15 and ERK2, which plays a critical role in the interaction of SMAD and non-SMAD signaling pathways to promote cartilage repair in experimental OA. Therefore, this specific mechanism can guide clinical treatments of OA.
What problem does this paper attempt to address?